Mar 08, 2022
Equity by Design in Clinical Research: Cancer trials – Module 1 Commitment to DEI
4:30 PM ET to 6:00 PM ET
EQUITY BY DESIGN IN CLINICAL RESEARCH: CANCER TRIALS is a virtual training course communicating an understanding of, and training on best practices for, diversity, equity, and inclusion (DEI) of underrepresented populations in clinical trials. The course is intended to aid cancer centers in improving their ability to enroll underrepresented participants in clinical research and to develop mechanisms for ongoing sustainability of DEI in clinical research. Ethical and regulatory considerations will be included, and practical guidance for commitment, communication, partnership, and conduct will be emphasized. CME credit available.
MODULE 1: COMMITMENT TO DEI
Commitment to DEI will describe the grounds for institutional and individual commitment to diversity, equity, and inclusion in clinical research, and illustrate how to substantiate commitment with actions, metrics, and resources.
Hosted by The Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard, The Center for Cancer Equity and Engagement at Dana-Farber/Harvard Cancer Center, and Mass General Brigham.